Kevin James Gillen,Jonathan Gillespie,Craig Jamieson,John Kinnaird Ferguson MacLean,Elizabeth Margaret Moir,Zoran Rankovic
申请号：
US13262992
公开号：
US20120202781A1
申请日:
2010.04.08
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to anindane derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising one or more of said indane derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and Alzheimers disease.
